(Q82640441)
Statements
Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial (English)
John J P Kastelein
Matthew A Cavender
Gregory Schwartz
David D Waters
Robert S Rosenson
Dianna Bash